Author:
Nabi Fahad,Dar Mohd Altaf,Malik Abrar Bashir
Abstract
Adverse drug responses, often known as ADRs, are a major cause for concern in contemporary medical treatment. These reactions are a major contributor to the morbidity and mortality rates of patients, as well as the rising expenditures of medical care. Because of their considerable understanding in drug management, patient education, and pharmacovigilance techniques, chemists are in a position to limit these risks in a way that is not possible with any other member of the healthcare team. The purpose of this research is to investigate the significant contribution that chemists play in the reduction of adverse drug reactions (ADRs), focussing on the impact that they have through patients' education, comprehensive medication therapy management (MTM), and active engagement in pharmacovigilance. The research also tackles difficulties such as excessive workloads and barriers to adverse drug reaction (ADR) reporting, and it proposes solutions to enhance the effectiveness of chemists in reducing adverse drug reactions (ADR). This review highlights the crucial role that chemists play in protecting the health of patients and enhancing the safety of medications by putting an emphasis on technical breakthroughs, constant professional growth, and collaboration across disciplines.